At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire ...

SINGAPORE] Boustead Singapore’s engineering and construction business unit, under its real estate solutions division Boustead ...

Siemens partners with Miko Pharma to develop cutting-edge pharmaceutical manufacturing facilities in Ghana. The agreement ...

Indian generic and formulation pharmaceutical (pharma) companies are contending with tariff-related challenges and subdued ...

The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical contract ...

s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing contract ... deal covers supply of both the active pharmaceutical ingredient, or API, and ...

Corporation has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International ...

Samsung Biologics has expanded its contract manufacturing business, adding 17 of the world’s top 20 pharmaceutical companies ...

ENCell, a bio-pharmaceutical contract development and manufacturing organization (CDMO), announced on the 4th that it has signed a CDMO contract worth 800 million won with the domestic corporation ...